Entity family

Browse funders

Organisations named as supporting, sponsoring, or funding research. Examples include Wellcome, NIHR, research councils.

3articles mentioning funders

3funder mentions

1distinct funders extracted

0%of mentions human-reviewed

Active filtersEntity: Merck ×

Merck

This funder is selected. Its supporting articles are shown below.

Articles mentioning Merck

3 articles · page 1 of 1

4CPS-191 Steady-state concentrations of clarithromycin under different routes of administration in pneumonia: risk factors and clinical outcomes

ejhpharm · abstract · 2026-03-18 · 1 matching annotations

88.9%

Merck pneumonia CLAR clarithromycin pulmonology department ICU

…MS/MS using a CLAR European Pharmacopoeia Reference Standard by Merck. The study received ethics approval (DE RKEB/IKEB: 7094-2025).R…

1343 A phase II trial of combination locoregional chemoimmunotherapy in recurrent platinum-sensitive ovarian cancer triggers a T lymphotactic response correlating with clinical outcomes

jitc · abstract · 2025-11-07 · 1 matching annotations

84.4%

Merck IV Pembrolizumab cisplatin Rintatolimod AIM Immunotech Epithelial ovarian cancer EOC

… the TME.Acknowledgements This trial receives support from both Merck and AIM Immunotech.References Heintz AP, et al. Carcinoma of th…

1346 Molecular and immunologic correlates of response in a phase II study of neoadjuvant lenvatinib plus pembrolizumab in Merkel cell carcinoma

jitc · abstract · 2025-11-07 · 1 matching annotations

93.6%

Merck NCI Merkel cell carcinoma pembrolizumab Lenvatinib H. Lee Moffitt Cancer Center & Research Institute MCC

…tance.Acknowledgements The authors acknowledge the support from Merck for support of the trial associated analysis of biospecimens. T…